Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity

This study investigated the immunogenicity of, and reactogenicity to, the ChAdOx1 nCoV-19 vaccine according to pre-existing adenovirus immunity. Individuals scheduled for COVID-19 vaccination were prospectively enrolled in a tertiary hospital with 2400 beds from March 2020 onwards. Pre-existing aden...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jinnam, Kim, Changhyup, Lee, Jung Ah, Lee, Se Ju, Lee, Ki Hyun, Kim, Jung Ho, Ahn, Jin Young, Jeong, Su Jin, Ku, Nam Su, Yeom, Joon-Sup, Song, Young Goo, Choi, Jun Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145356/
https://www.ncbi.nlm.nih.gov/pubmed/37112696
http://dx.doi.org/10.3390/vaccines11040784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145356/
https://www.ncbi.nlm.nih.gov/pubmed/37112696
http://dx.doi.org/10.3390/vaccines11040784

Ejemplares similares